Your browser doesn't support javascript.
loading
A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression.
Naderinezhad, Samira; Zhang, Guoliang; Wang, Zheng; Zheng, Dayong; Hulsurkar, Mohit; Bakhoum, Michael; Su, Ning; Yang, Han; Shen, Tao; Li, Wenliang.
Afiliação
  • Naderinezhad S; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
  • Zhang G; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Wang Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Zheng D; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Hulsurkar M; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
  • Bakhoum M; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Su N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Yang H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Shen T; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • Li W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. Electronic address: wenliang.li@uth
Cancer Lett ; 571: 216333, 2023 09 01.
Article em En | MEDLINE | ID: mdl-37543278
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Quinase 3 de Receptor Acoplado a Proteína G / Histona Desacetilase 2 Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Quinase 3 de Receptor Acoplado a Proteína G / Histona Desacetilase 2 Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos